Skip to main content
logo
Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada flag Canada · Delayed Price · Currency is CAD
0.1200
0.00 (0.00%)
Apr 10, 2026, 12:50 PM EST

Voyageur Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Market Cap
21299589
Market Cap Growth
-10.95%215.19%70.79%-34.31%-11.82%221.01%
Enterprise Value
21.228.358.945.358.078.38
Last Close Price
0.120.160.070.040.070.09
PE Ratio
--8.00-6.50-4.00-3.50-4.50
PS Ratio
1834.012445.35----
PB Ratio
17.1122.8120.153.705.524.81
P/TBV Ratio
15.8721.1619.883.645.154.47
P/FCF Ratio
--9.88-29.99-5.35-4.69-5.49
P/OCF Ratio
--9.88-29.99-5.35-4.70-5.56
EV/Sales Ratio
-2425.92----
EV/EBITDA Ratio
--8.03-5.24-3.83-4.62-4.10
EV/EBIT Ratio
--8.02-5.24-3.82-4.59-4.08
EV/FCF Ratio
-6.70-9.80-29.57-5.39-4.69-5.02
Debt / Equity Ratio
0.030.030.090.030.020.01
Debt / EBITDA Ratio
-0.01-0.01-0.02-0.03-0.01-0.02
Debt / FCF Ratio
-0.01-0.01-0.13-0.04-0.01-0.02
Net Debt / Equity Ratio
-0.18-0.18-0.280.030.00-0.40
Net Debt / EBITDA Ratio
0.060.060.07-0.030.000.38
Net Debt / FCF Ratio
0.080.080.42-0.040.000.46
Asset Turnover
0.000.000000
Inventory Turnover
0.200.200000
Quick Ratio
0.220.220.100.060.091.38
Current Ratio
0.330.330.170.130.271.43
Return on Equity (ROE)
-415.01%-415.01%-181.07%-96.50%-104.07%-185.44%
Return on Assets (ROA)
-132.51%-123.87%-71.70%-65.72%-75.42%-106.79%
Return on Invested Capital (ROIC)
-464.36%-434.10%-171.32%-94.55%-133.10%-230.63%
Return on Capital Employed (ROCE)
-420.71%-393.29%-171.26%-93.49%-101.93%-177.57%
Earnings Yield
-16.48%-12.50%-15.38%-25.00%-28.57%-22.22%
FCF Yield
-14.76%-10.12%-3.33%-18.67%-21.30%-18.22%
Buyback Yield / Dilution
-20.37%-20.37%-5.46%-21.03%-13.89%-34.24%
Total Shareholder Return
-20.37%-20.37%-5.46%-21.03%-13.89%-34.24%
Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.